Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Diabetes|January 1, 1995
Tissue factor pathway inhibitor activity in patients with IDDMP B Leurs, R van Oerle, K Hamulyak, et al.Thrombosis and Haemostasis|March 1, 1997
Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitusP B Leurs, R van Oerle, B H Wolffenbuttel, et al.Diabetic Medicine : a Journal of the British Diabetic Association|January 10, 2003
Tissue factor pathway inhibitor (TFPI) release after heparin stimulation is increased in Type 1 diabetic patients with albuminuriaP B Leurs, R van Oerle, K Hamulyak, et al.American Journal of Clinical Pathology|May 1, 1997
The clinical application of a new specific functional assay to detect the factor V(Leiden) mutation associated with activated protein C resistanceR van Oerle, L van Pampus, G Tans, et al.Scandinavian Journal of Clinical and Laboratory Investigation|December 10, 2002
Identification of determinants of the between-operator variation of the total protein S antigen assay: a collaborative study of the Dutch Working Group on Haemostasis Laboratory DiagnosisP Meijer, H W Verbruggen, B De Weerd, et al.Journal of Thrombosis and Haemostasis : JTH|May 25, 2011
Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia AM Ninivaggi, Y Dargaud, R van Oerle, et al.Scandinavian Journal of Clinical and Laboratory Investigation|May 15, 2002
Effect of a common reference plasma on the inter-laboratory variation of the measurement of total and free protein S: a collaborative study of the Dutch Working Group on Haemostasis Laboratory DiagnosisP Meijer, H W Verbruggen, B de Weerd, et al.British Journal of Haematology|February 13, 2001
Tissue factor activity in human monocytes is regulated by plasma: implications for the high and low responder phenomenonM Nijziel, R van Oerle, C van 't Veer, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 19, 2015
Biomarkers for Prediction of Central Venous Catheter Related-Thrombosis in Patients With Hematological MalignanciesR S Boersma, K Hamulyak, R van Oerle, et al.Phlebology|March 29, 2013
In vivo effects of foam sclerotherapy on coagulationN H Shadid, S K van der Velden, R van Oerle, et al.Pageof 4